{
    "paper_id": "1714d3fbd1b8622c8c01ac242130d85b2e74dba9",
    "metadata": {
        "title": "In Vivo Assembly of Nanoparticles Achieved through Synergy of Structure-Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive Immunity",
        "authors": [
            {
                "first": "Ziyang",
                "middle": [],
                "last": "Xu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Megan",
                "middle": [
                    "C"
                ],
                "last": "Wise",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Neethu",
                "middle": [],
                "last": "Chokkalingam",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Susanne",
                "middle": [],
                "last": "Walker",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Edgar",
                "middle": [],
                "last": "Tello-Ruiz",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Sarah",
                "middle": [
                    "T C"
                ],
                "last": "Elliott",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Alfredo",
                "middle": [],
                "last": "Perales-Puchalt",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Peng",
                "middle": [],
                "last": "Xiao",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Xizhou",
                "middle": [],
                "last": "Zhu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ruth",
                "middle": [
                    "A"
                ],
                "last": "Pumroy",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Paul",
                "middle": [
                    "D"
                ],
                "last": "Fisher",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Katherine",
                "middle": [],
                "last": "Schultheis",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Eric",
                "middle": [],
                "last": "Schade",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Sergey",
                "middle": [],
                "last": "Menis",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Stacy",
                "middle": [],
                "last": "Guzman",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Hanne",
                "middle": [],
                "last": "Andersen",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Kate",
                "middle": [
                    "E"
                ],
                "last": "Broderick",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Laurent",
                "middle": [
                    "M"
                ],
                "last": "Humeau",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Kar",
                "middle": [],
                "last": "Muthumani",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Vera",
                "middle": [],
                "last": "Moiseenkova-Bell",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "William",
                "middle": [
                    "R"
                ],
                "last": "Schief",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "David",
                "middle": [
                    "B"
                ],
                "last": "Weiner",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Daniel",
                "middle": [
                    "W"
                ],
                "last": "Kulp",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "f. Comparison of humoral responses induced by two 10ug doses of DLnano_LS_HA_NC99, which homogeneously assembled and by DNA-encoded LS_HA_CA09, which did not homogeneously assemble in vitro. n=5 per group; each dot represents an animal; error bar represents standard deviation; two-tailed Mann-Whitney Rank Test used to compare groups; pvalues were adjusted for multiple comparison where appropriate; *, p<0.05.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Improved protection from lethal H1/CA09 challenge in mice with DLnano_3BVE_HA_CA09 vaccination. a. SEC trace for lectin-purified recombinantly 11",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "H&E stain for lung histo-pathology in remaining 12 mice seven days post viral challenge or at the time of euthanasia as in Figure. 6e. 1ug DNA dose used in vivo for c and d. n=5 per group",
            "authors": [],
            "year": null,
            "venue": "Figure. 6e. d",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "In vitro expression of protein eOD-GT8-60mer and GT8-monomer and in vivo expression and assembly of DLnano_LS_GT8 and DLmono_GT8. a.Immunofluorescence analyses of intracellular expression of protein eOD-GT8-monomer and -60mer with or without IgE leader sequence in transfected HEK293T cells as determined by staining with VRC01 (green) and DAPI (blue) staining. b. Reducing SDS-PAGE analysis of Expi293F transfection supernatants of pVAX backbone plasmid, protein GT8-monomer,protein eOD-GT8-60mer. c. SEC trace of lectin column purified Expi293F transfection supernatant of eOD-GT8-60mer. d-e. Binding of in vitro produced protein eOD-GT8-monomer and eOD-GT8-60mer to VRC01 (d.) and MBL (e.) in ELISA assays. f-g. Binding of in vivo expressed DLmono_GT8 and DLnano_LS_GT8 seven d.p.i to VRC01 (f.) and MBL (g.) in the ELISA assays. h. Additional TEM images of muscle sections from mice injected with DLmono_GT8 and DLnano_LS_GT8. i. Quantitative determination of the frequencies of clusters of different orders in the TEM images; *, p<0.05. 80ug of plasmid DNA used in vivo for panels f through i. Humoral responses induced by DLnano_LS_GT8 versus DLmono_GT8 vaccination in female BALB/c, C57BL/6 and CD1 mice. a. ELISA binding against monomeric GT8 using serum from BALB/c immunized with 1:1 ratio (25ug each) of DLmono_GT8 with pVAX backbone plasmid, DLmono_GT8 with DLnano_LS(core) or DLnano_LS_GT8 with pVAX backbone seven d.p.i. b. Endpoint titers at seven d.p.i in BALB/c mice immunized with DLmono_GT8, DL_GT8_IMX313P, or DLnano_LS_GT8. c. IgM endpoint titers to GT8 over time in BALB/c mice immunized with two doses of DLmono_GT8, or DLnano_LS_GT8. d. Endpoint titers to GT8 over time using serum from BALB/c receiving single immunizations of DLmono_GT8 or DLnano_LS_GT8. e. Flow plot demonstration of 5 gating of antigen-specific GT8-Tetramer-APC+ GT8-24mer-FITC+ CD19+IgM-IgD-IgG+ Bcells in the spleens of BALB/c mice immunized with two doses of DLmono_GT8 or DLnano_LS_GT8 five weeks post the second immunization f. ELISA data showing competition of VRC01 binding at its corresponding EC70 concentration to GT8 by week five post-immune sera from mice immunized with two doses of DLmono_GT8 or DLnano_LS_GT8. g. Endpoint titers to GT8 using serum for BALB/c receiving two immunizations of varying doses of DLmono_GT8. h. Endpoint titers to GT8 using serum from BALB/c mice receiving two immunizations of varying doses of DLnano_LS_GT8. i. Humoral responses in C57BL/6 mice immunized with two doses of DLmono_GT8 or DLnano_LS_GT8. j. Humoral responses in CD1 mice immunized with two doses of DLnano_LS_GT8 or DLmono_GT8. 25ug of plasmid DNA used in these experiments unless otherwise specified. n=5 for BALB/c and C57BL/6 mice, n=10 for CD1 mice; each line represents an animal; error bar represents standard deviation; arrow below the plot represents an immunization; *, p<0.05. Generalizability of improved cellular responses of DLnano_LS_GT8 in BALB/c, C57BL/6 and CD1 mice strains; comparison of induced CD8+ T-cell responses by protein eOD-GT8-60mer versus DLnano_LS_GT8 in C57BL/6 mice. a and b. Frequencies of TNFa and IL-2 expressing CD4+ effector memory T-cells specific to either the LS and GT8 domains in female BALB/c mice immunized twice with DLmono_GT8 or DLnano_LS_GT8.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "c. Comparisons of total cellular responses to the LS and GT8 domains as assessed byIFN-\u03b3    ELISpot assay in female C57BL/6 versus BALB/c mice. d. and e.Comparison of CD4+ (d.)    and CD8+ (e.) effector memory T-cell responses to the LS and GT8 domains in female C57BL/6 and BALB/c mice. f-h. Overall T-cell (f), CD4+ effector memory (g), and CD8+ effector memory (h) T-cell responses in female CD1 mice immunized with two doses ofDLnano_LS_GT8 as compared to DLmono_GT8. i. Frequencies of effector memory CD8+ Tcells in female C57BL/6 and CD1 mice immunized twice with DLnano_LS_GT8 and DLmono_GT8. j. Comparison of frequencies of GT8-specific CD8+ T-cell responses induced by two immunizations of DLnano_LS_GT8 versus DLmono_GT8 in male BALB/c mice. k. CD4+ effector memory T-cell responses induced by protein eOD-GT8-60mer and DLnano_LS_GT8 in C57BL/6 mice as determined by ICS. l. Flow plot demonstrating induction of CD8+ effector memory T-cell responses by DLnano_LS_GT8 in comparison to protein eOD-GT8-60mer in C57BL/6 mice as determined. 25ug plasmid DNA and 10ug recombinant protein used in the figure unless otherwise specified. n=5 for BALB/c and C57BL/6 mice, n=10 for CD1 mice; each dot represents an animal; error bar represents standard deviation; two-tailed Mann-Whitney Rank Test used to compare groups; *, p<0.05; ***, p<0.0005. 8 Supplemental Figure. 4. Characterization of biophysical profiles and immune responses induced by newly designed DLnano GT8-vaccines with alternative scaffolds. a. SEC trace of recombinantly produced designed 3BVE-GT8. b. SEC trace of designed PfV_GT8 immunogen shows partial assembly into the 180-mer form. c. Binding of in vitro produced protein GT8monomer, 3BVE_GT8, eOD-GT8-60mer and PfV_GT8 to VRC01 by ELISA. d and e. Effector memory T-cell responses to GT8 domain in BALB/c mice immunized with two doses of 25ug DLmono_GT8, DLnano_3BVE_GT8, DLnano_LS_GT8 and DLnano_PfV_GT8 by IFN\u03b3 ELIspots (d) and ICS for CD8+ T-cells (e). n=5 per group; each dot represents an animal; error bar represents standard deviation; two-tailed Mann-Whitney Rank Test used to compare groups; p-values were adjusted for multiple comparison where appropriate; *, p<0.05. 9 Supplemental Figure. 5. Characterization of biophysical profiles and immune responses induced by newly designed DLnano influenza hemagglutinin-based vaccines. a. SEC trace of recombinantly produced designed LS_HA_NC99 nanoparticles. b. Binding of sera from BALB/c mice immunized with 1ug DLnano_LS_HA_NC99 or DLmono_HA_NC99 at 56 d.p.i (post-dose #3) to heterologous recombinant H1 (SI06) hemagglutinin protein. c and d. CD8+ effector memory T-cell responses to NC99 HA domain in BALB/c mice immunized with two 10ug doses of DLmono_HA_NC99 or DLnano_LS_HA_NC99 in terms of IFN\u03b3 (c.) and CD107a (d.) expression. e. SEC trace of lectin purified recombinantly produced LS_HA_CA09.",
            "latex": null,
            "type": "figure"
        }
    },
    "back_matter": []
}